InvestorsHub Logo
Post# of 176639
Next 10
Followers 7
Posts 758
Boards Moderated 0
Alias Born 10/11/2018

Re: None

Thursday, 01/10/2019 2:17:58 PM

Thursday, January 10, 2019 2:17:58 PM

Post# of 176639
Y-90 for liver cancer
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230849/
Hepatobiliary Surg Nutr. 2018 Oct;7(5):382-385.
doi: 10.21037/hbsn.2018.06.09.
The role of selective internal radiotherapy with Y-90 resin microsphere in first-line therapy for hepatic colorectal metastases.

Yttrium-90 is a high-energy, pure ß-emitter with a half-life of 64 hours and maximum tissue penetration of 11 mm, which makes it very suitable for treatment of liver tumours. Yttrium-90 is relatively straightforward to use, with limited issues relating to radioprotection for the patient, family or attending staff.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News